The Role of Biomarkers in the Occurrence and Development of Asthma
Recruiting now
Conditions studied: Asthma in Children
In brief
To study the expression level of biomarkers such as GITRL in peripheral blood of children with asthma and analyze their correlation with the severity of asthma. To study the predictive value of biomarkers level for the occurrence and development of asthma. And to provide supplementary detection means and predictive indicators for the diagnosis of asthma and the severity of asthma.
Key facts
- Study ID
- NCT05768399
- Run by
- Children's Hospital of Chongqing Medical University
- People needed
- 2
- Starts
- 2023-07-04
- Expected to finish
- 2029-12-31
- Last updated by the study team
- 2023-07-07
Who can join
Age: 4 and older, up to 12. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- In line with the diagnostic criteria in the Guidelines for the Diagnosis and Prevention of Bronchial Asthma in Children (2016 Edition)
- Age: 4-12 years old for new diagnosis or recurrent episodes
- Typical clinical manifestations and complete clinical data
- Family members or guardians of children with informed research and signed consent
- All healthy control subjects had no history of lung disease, allergic rhinitis or any other atopic disease
You may not qualify if…
- Suffering from other respiratory diseases (such as bronchiectasis, allergic rhinitis, respiratory failure, tuberculosis, obstructive airway disease) or other inflammatory diseases.
- Abnormal development of congenital airway and lung tissue
- History of immunosuppressant or glucocorticoid use in the first 4 weeks
- Suffering from other endocrine system and immune system diseases
- Incomplete clinical data or examinations.
Where it is running
- Shaoqing Zhang — Chongqing, Chongqing Municipality, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.